27
SUPLEMENTO
abstracts
Academia Española
deDermatología yVenereología
Actual.Med.
2014; 99: (792). Supl. 27-60
Referencias:
1.
Athreya BH. Vasculitis in children. Paediatric Clin Am
1995;42:1239-1261.
2.
Gardner-Medwin JM, Dolezalova P, Cummins C, et al. Inci-
dence of Henoch-Scho¨nlein purpura, Kawasaki disease, and
rare vasculitides in children of different ethnic origins. Lancet
2002;360:1197–202.
3.
BowyerS,RoettcherP.Pediatric rheumatologyclinicpopulations
in theUnited States: results of a 3 year survey. Pediatric Rheu-
matologyDatabaseResearchGroup. JRheumatol 1996;23:1968.
4.
Athreya BH. Vasculitis in children. Paediatric Clin Am.
1995;42.1239-1261.
5.
Symmons DPM, JonesM, Osborne J, et al. paediatric rheuma-
tology in the United Kingdom:data from the British Paediatric
RheumatologyGroupNational Diagnostic register. J Rheumatol.
1986;23:1975-1981.
6.
Malleson PN, Fung MY, Rosenberg AM. The incidence of pe-
diatric rheumatic disease: Results from the Canadian Paedia-
tric rheumatology Association Disease Registry. J Rheumatol
1996;23:1981-1987.
7.
LaneSE,WattsRA,ShepstoneL.Primarysystemicvasculitis:clini-
cal featuresandmortality.QJM.2005;98(2):97-111.
8.
Lie JT.Nomenclatureandclassificationofvasculitis:pluscachan-
ge, plus c est lameme chose. Arthritis Rheum. 1994;37(2):181-
86.
9.
Sundel R, Szer I. Vasculitis in childhood. Rheum Dis Clin Am.
2002;28:625-54.
10. Jennette JC, Falk RJ, Andrassy K. Nomenclatureof systemic vas-
culitides: proposal of an international consensusconference.Ar-
thritisRheum.1994;37:187-92.
11. SavageCOS,HarperL,AduD.Primarysystemicvasculitis. Lancet.
1997;22:553-58.
12. Ozen S, Ruperto N, Dillon MJ. EULAR/PReS endorsed consen-
sus criteria for the classifi cation of childhood vasculitides. Ann
RheumDis.2006;65:936-41.
13. RupertoN, Ozen S, Pistorio A. EULAR/PRINTO/PRES criteria for
Henoch-Schönleinpurpura, childhoodpolyarteritisnodosa, chil-
dhoodWegener granulomatosis and childhood Takayasu arteri-
tis: Ankara2008, Part I-Overallmethodologyand clinical charac-
terisation.AnnRheumDis.2010;69:790-97.
14. Ozen S, Pistorio A, Lusan SM. EULAR/PRINTO/PRES criteria for
Henoch-Schönleinpurpura, childhoodpolyarteritisnodosa, chil-
dhoodWegener granulomatosis and childhood Takayasu arteri-
tis: Ankara 2008, Part II-Final classification criteria. Ann Rheum
Dis.2010;69:798-806.
15. Weiss PF, Feinstein JA, Luan X, et al. Effects of corticosteroid
on Henoch-Schönlein purpura: a systematic review. Pediatrics
2007;120:1079–87.
16. JauholaO, Ronkainen J, KoskimiesO, et al. Renalmanifestations
ofHenoch-Schönleinpurpura ina6-monthprospective studyof
223children.ArchDisChild2010;95:877–82.
17. Holman RC, Belay ED, Christensen KY, et al. Hospitalizations for
Kawasaki syndromeamong children in theUnitedStates, 1997–
2007.Pediatr InfectDis J2010;29:483–8.
18. Newburger JW, Takahashi M, Burns JC, et al. The treatment of
Kawasaki syndromewith intravenous gamma globulin. N Engl J
Med1986;315:341–7.
19. MolloyES, LangfordCA.Advances in the treatmentof small ves-
sel vasculitis.RheumDisClinNorthAm2006;32:157–72, x.
20. Jennette JC, Falk RJ, Andrassy K. Nomenclatureof systemic vas-
culitides: proposal of an international consensusconference.Ar-
thritisRheum.1994;37:187–92.
